Agger Mette Kirstine — SEC Form 4 filings

SEC reporting owner CIK 1722234. 7 Form 4 filings on record with FilingPulse; latest filed 2026-06-29.

Transaction summary — filings shown

Covers all 7 filings on record, filed 2024-02-06 to 2026-06-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Lexeo Therapeutics, Inc. (LXEO)Director44
scPharmaceuticals Inc. (SCPH)Director34

Form 4 filings — Agger Mette Kirstine

FiledFormIssuerReported transactionsSource
2026-06-294Lexeo Therapeutics, Inc. (LXEO)Grant/award (A): 35,000 (derivative) @ $0EDGAR
2025-10-074scPharmaceuticals Inc. (SCPH)Disposition to issuer (D): 30,000 (derivative) @ $0 · Disposition to issuer (D): 19,750 (derivative) @ $0EDGAR
2025-06-304Lexeo Therapeutics, Inc. (LXEO)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2025-06-054scPharmaceuticals Inc. (SCPH)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2024-06-274Lexeo Therapeutics, Inc. (LXEO)Grant/award (A): 18,000 (derivative) @ $0EDGAR
2024-06-134scPharmaceuticals Inc. (SCPH)Grant/award (A): 19,750 (derivative) @ $0EDGAR
2024-02-064Lexeo Therapeutics, Inc. (LXEO)Grant/award (A): 36,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1722234 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →